40 Kda peginterferon alfa-2a (Pegasys): efficacy and safety results from a phase II, randomized, actively controlled, multicenter study in the treatment of HBVEAG positive chronic hepatitis B - Cooksley,W.GE.; Piratvisuth,T.; Wang,Y-J. (Hepatology, 2001)